Form 4 for CING Cingulate Inc.
Accepted 2026-02-10 00:00:00 ET · period of report 2026-02-06 · accession 0001493152-26-006024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-10 | 2026-02-06 | CING | Brams Matthew | EVP, Chief Medical Off | P - Purchase | $5.04 | +1,946 | 4,656 | +72% | +$9,808 |
| D | 2026-02-10 | 2026-02-06 | CING | Brams Matthew | EVP, Chief Medical Off | P - Purchase | $0.1 | +1,556 | 1,556 | New | +$155.60 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-06 | P | A | 1,946 | $5.04 | 4,656 | D | — | — | (F1) Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026. |
| 2 | Derivative | Warrant to Purchase Common Stock | 2026-02-06 | P | A | 1,556 | $0.1 | 1,556 | D | $5.04 · — to — | 1,556 Common Stock | (F1) Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026. (F2) The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date. |